Literature DB >> 22258361

The VAS-COG clinic: an out-patient service for patients with cognitive and behavioral consequences of cerebrovascular diseases.

Laura Ciolli1, Anna Poggesi, Emilia Salvadori, Raffaella Valenti, Serena Nannucci, Marco Pasi, Francesca Pescini, Domenico Inzitari, Leonardo Pantoni.   

Abstract

Services dedicated to patients with cognitive and behavioral consequences of cerebrovascular diseases (CVD) are not established. We started an out-patient clinic (the "VAS-COG clinic") to assess patients with psycho-cognitive disturbances related to CVD. The work-up includes a clinical-neuroimaging diagnostic process and the individuation of the best therapeutic strategies as done in patients with neurodegenerative cognitive impairment. We report the results of the first 5 years of activity. Reasons for patient referral were not only cognitive, language, gait, and psychiatric disturbances related to stroke or chronic CVD, but also neuroimaging evidence of vascular encephalopathy and screening for familial microangiopathies. The patients were evaluated with uniformed protocols. From January 2006 to November 2010, we evaluated 403 patients. Of these, 374 (93%; mean age 69.7 years ± 15.0) were considered appropriate for the VAS-COG clinic. The following diagnoses were made: vascular dementia (8.6%), Alzheimer disease (2.1%), mixed dementia (vascular plus degenerative) (4.8%), vascular mild cognitive impairment (MCI) (9.1%), amnesic-MCI (8.0%), mixed-MCI (4.8%), post-stroke depression (2.7%), post-stroke language disturbances (4.5%), subjective memory complaint (1.3%), familiar microangiopathy (31.3%), vascular encephalopathy evidenced by neuroimaging not associated with specific clinical disturbances (15.3%), and other conditions (7.5%). Psycho-cognitive disturbances associated with CVD are heterogeneous. In addition to acute stroke care strategies, long-term assessment of patients with CVD is required. The VAS-COG clinic may represent a model in this regard and might be important for improving the care of patients and offering counseling to their families. The efficacy of this service needs, however, to be proved by successive work.

Entities:  

Mesh:

Year:  2012        PMID: 22258361     DOI: 10.1007/s10072-012-0941-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  38 in total

1.  The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond.

Authors:  Jack C de la Torre
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

2.  Poststroke cognition and the fight against the hard problem: vascular neurologists, enter the arena!

Authors:  Jan Lodder
Journal:  Stroke       Date:  2006-12-07       Impact factor: 7.914

3.  Geriatric Depression Scale.

Authors:  J A Yesavage
Journal:  Psychopharmacol Bull       Date:  1988

4.  Frequency of depression after stroke: a systematic review of observational studies.

Authors:  Maree L Hackett; Chaturangi Yapa; Varsha Parag; Craig S Anderson
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

Review 5.  Monogenic vessel diseases related to ischemic stroke: a clinical approach.

Authors:  E Ballabio; A Bersano; N Bresolin; L Candelise
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-20       Impact factor: 6.200

6.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

7.  Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type.

Authors:  M J De Leon; S H Ferris; A E George; B Reisberg; I I Kricheff; S Gershon
Journal:  Neurobiol Aging       Date:  1980       Impact factor: 4.673

8.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients.

Authors:  L Pantoni; F Pescini; S Nannucci; C Sarti; S Bianchi; M T Dotti; A Federico; D Inzitari
Journal:  Neurology       Date:  2010-01-05       Impact factor: 9.910

10.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.

Authors:  Domenico Inzitari; Giovanni Pracucci; Anna Poggesi; Giovanna Carlucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni
Journal:  BMJ       Date:  2009-07-06
View more
  2 in total

1.  1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.

Authors:  Charles Gasparovic; Jillian Prestopnik; Jeffrey Thompson; Saeid Taheri; Branko Huisa; Ronald Schrader; John C Adair; Gary A Rosenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-16       Impact factor: 10.154

2.  Web-based cognitive training: patient adherence and intensity of treatment in an outpatient memory clinic.

Authors:  Vítor Tedim Cruz; Joana Pais; Ivânia Alves; Luís Ruano; Cátia Mateus; Rui Barreto; Virgílio Bento; Márcio Colunas; Nelson Rocha; Paula Coutinho
Journal:  J Med Internet Res       Date:  2014-05-07       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.